Synthetic Heterocycles for Anticancer Applications
Summary
Synthetic heterocycles—ring systems incorporating at least one atom other than carbon—have emerged as versatile scaffolds in the design of anticancer agents. Their structural diversity allows precise tuning of electronic and steric properties to target intracellular pathways that drive tumour growth. Key classes include pyrazolo-fused pyridines and pyrimidines, which engage kinases, DNA polymerases and other regulatory proteins. Structure–activity relationship studies guide the optimisation of substituents to enhance potency and selectivity, while parallel ADME (absorption, distribution, metabolism and excretion) profiling ensures favourable pharmacokinetic properties. Advances in synthetic methodology, such as multicomponent and cascade cyclisation reactions, have streamlined access to complex heterocycles with high atom economy. In vitro and in vivo models demonstrate that appropriately designed heterocycles can arrest cell-cycle progression, induce apoptosis and overcome multidrug resistance. Globally, these compounds hold promise for combination regimens and precision medicine, offering chemically tractable leads for translation into clinical candidates against diverse malignancies.
Research from Nature Portfolio
No recent Nature Portfolio content available.
Synthetic Heterocycles for Anticancer Applications publication trend
The graph below shows the total number of articles in synthetic heterocycles for anticancer applications across all publications each year (not limited to Nature Index journals).
Technical terms
Heterocycle: A cyclic compound featuring one or more non-carbon atoms (such as nitrogen or sulfur) in the ring structure.
Pyrazolo[3,4-b]pyridine: A bicyclic heterocycle formed by the fusion of a pyrazole ring to a pyridine ring, often used in kinase inhibitor design.
Pyrazolo[1,5-a]pyrimidine: A fused ring system consisting of a pyrazole moiety joined to a pyrimidine ring, valued for diverse biological activities.
Structure–activity relationship (SAR): Analysis of how variations in chemical structure correlate with changes in biological efficacy or selectivity.
IC₅₀: The concentration of a compound required to inhibit a given biological process or enzyme by 50%, a standard measure of potency.
ADME: An acronym for absorption, distribution, metabolism and excretion, describing key pharmacokinetic processes that determine a drug’s behaviour in vivo.
Tropomyosin receptor kinase A (TrKA): A receptor tyrosine kinase involved in cell survival signalling, representing a target for anticancer intervention.
References
- Discovery of New 1,4,6-Trisubstituted-1H-pyrazolo[3,4-b]pyridines with Anti-Tumor Efficacy in Mouse Model of Breast Cancer †. Pharmaceutics (2023).
- Synthesis, anticancer evaluation, molecular docking and ADME study of novel pyrido[4ʹ,3ʹ:3,4]pyrazolo[1,5-a]pyrimidines as potential tropomyosin receptor kinase A (TrKA) inhibitors. BMC Chemistry (2024).
About these summaries
This Nature Research Intelligence Topic summary is created with the cited references and a large language model. We take care to ground generated text with facts, and have systems in place to gain human feedback on the overall quality of the process in line with our AI principles. We strive to create accurate and useful summaries for people unfamiliar with the research topic and that supports this goal. These pages are a beta release and will be updated as we learn how best to help people gain value from a research topic summary.
Turn complex research questions into confident strategic decisions
When you're under pressure to set direction, justify investment, or understand your competitive position, you need more than raw data — you need trusted insights you can act on.
Benchmark your performance against global peers using robust, methodologically sound analysis.
Combine quantitative metrics with qualitative expert insight to uncover strengths, gaps and emerging opportunities.
Gain tailored, decision-ready recommendations aligned to your strategic priorities.
Talk to us to learn more about our data dashboards and bespoke strategy reports.
Grow research skills, confidence and careers with training built for every stage of the research lifecycle.
Developed with Nature Portfolio journal Editors and internationally renowned experts. Discover three ways to learn:
Self-paced, online courses in convenient bite-sized units, covering key skills across scientific writing, publishing, grant writing, data analysis, and more.
Expert trainer-led workshops with hands-on exercises and real-time feedback across core research skills, delivered via interactive group sessions.
Editor-led workshops combining core principles in writing and publishing, personalised 1:1 feedback from Nature Portfolio Editors and hands-on exercises.
Explore course catalogues and workshop agendas, enquire about the options or request institutional pricing.